Navigation Links
OFS to Present Paper on Optical Fibers with Polyimide Coatings for Medical Applications
Date:1/19/2012

AVON, Conn., Jan. 19, 2012 /PRNewswire/ -- The Specialty Photonics Division of OFS Fitel, LLC (OFS SPD), a leading provider of optical fiber, cable, and assemblies for medical device manufacturers, announces that Dr. Andrei Stolov will present "Optical fibers with polyimide coatings for medical applications" at the upcoming BiOS Technology Conference. Dr. Stolov will present on Sunday, January 22nd at 12:10 PM, in room 206 (Mezzanine).

(Logo:  http://photos.prnewswire.com/prnh/20120119/CL38819LOGO )

The focus of the work was to model extreme conditions that optical fibers may encounter in medical applications. Three commercially available fibers were examined. A battery of tests were completed analyzing how well each fiber withstood exposure to extreme heat and humidity, multiple autoclave cycles, extended water soak, and immersion in organic solvents. Key properties of polyimide-coated optical fibers, un-aged and exposed to various harsh environments, were investigated. Dr. Stolov commented that "The results of the work will certainly be of interest to engineers who are either evaluating or thinking of evaluating polyimide-coated fibers for their medical application."

OFS SPD will exhibit and showcase its line of optical fiber, cable, and assemblies for the medical market at the BiOS Tradeshow, January 21st-22nd.

About OFS

OFS is a world-leading designer, manufacturer and provider of optical fiber, optical fiber cable, FTTX, optical connectivity and specialty photonics products. Our manufacturing and research divisions work together to provide innovative products and solutions that traverse many different applications as they link people and machines worldwide. Between continents, between cities, around neighborhoods, and into homes and businesses of digital consumers we provide the right optical fiber, optical cable and components for effi
'/>"/>
SOURCE OFS, Specialty Photonics Division
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
8. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
9. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. ViroPharma to Present at Three Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... NEWS, Virginia , 11. Juli ... Hersteller von Kameras für die molekulare ... (MBI/BSGI), hat heute die CE-Zulassung für ... dem CE-Zeichen kann Dilon das Produkt ... Vertriebsbereich auf den Großteil der europäischen ...
(Date:7/10/2014)... 2014  The U.S. Department of Health and Human ... Hospitals (UH) Case Medical Center Seidman Cancer Center totaling ... at improving care for patients with complex cancer. ... test a unique model developed at UH to enhance ... comorbidities, or demonstrated need for high health care utilization.  ...
(Date:7/10/2014)... Calif. , July 10, 2014  Breg, ... and services, has launched the FreeRunner™ knee brace ... who suffer from patella mal-tracking return to active ... differently than other braces, providing support when patients ... normally when they don,t. Patellofemoral issues ...
Breaking Medicine Technology:Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2
(Date:7/10/2014)... Denver, CO (PRWEB) July 11, 2014 ... Vicki Cowart, President and CEO of Planned Parenthood of ... the fact Senator Mark Udall and Representative Diana DeGette ... the Supreme Court’s Hobby Lobby decision and keeping bosses ... and PPRM representatives listened to the president today in ...
(Date:7/10/2014)... 11, 2014 The Capital Institute for ... the first procedure in a clinical trial that delivers ... the leg. , During the procedure, done at Capital ... endovascular neurosurgeon, threaded a tiny catheter through the patient’s ... and neck and into the brain. Once the catheter ...
(Date:7/10/2014)... Mice consuming a supplement of omega 3 fatty acids ... saturated fats and omega 6 fatty acids, according to ... Annals of the Rheumatic Diseases (10.1136/annrheumdis-2014-205601) on ... not just obesity may contribute to worsening osteoarthritis. ... more significant role than mechanical factors in the link ...
(Date:7/10/2014)... 2014 More than 200 experts on ... urban street violence, will attend the 21st World Meeting ... (ISRA) at the Loews Atlanta Hotel, July 15-19. ... prestigious world meeting, which is held every other year ... bringing together leading scholars from more than 20 different ...
(Date:7/10/2014)... Fatigue, lack of safety equipment and ... accidents in the workplace, according to a series ... safety issues that contribute to the alarming workplace ... the job annually, according to the International Labor ... workplace accidents." , Safety Issue: "Extended Work Hours ...
Breaking Medicine News(10 mins):Health News:Naral Pro-Choice Colorado & Planned Parenthood Of The Rocky Mountains Statement On Udall & Degette Staying In Dc To Introduce Legislation 2Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 2Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 3Health News:Omega 3 fatty acids lessen severity of osteoarthritis in mice 2Health News:Georgia State Hosts National Conference On Aggression 2Health News:Georgia State Hosts National Conference On Aggression 3Health News:Georgia State Hosts National Conference On Aggression 4Health News:Safety Reboot Magazine Focuses on: Why Extended Hours is Dangerous in the Workplace; Why Custodial Work Can be Dangerous; and Improving Safety for Roofers 2Health News:Safety Reboot Magazine Focuses on: Why Extended Hours is Dangerous in the Workplace; Why Custodial Work Can be Dangerous; and Improving Safety for Roofers 3
... 7 Vion,Pharmaceuticals, Inc. (Nasdaq Capital Market: VION) ... that the Company had regained,compliance with Marketplace Rule ... Stock had traded at $1.00 per share or ... Vion Pharmaceuticals, Inc. is committed to extending the ...
... MGT Capital Investments,Inc. (Amex: MGT ), ... ("HCIT") sector, today commented on the American Cancer,Society,s ... its colon cancer screening guidelines. MGT Capital Investment,s,Medicsight ... exchange under,"MDST," is an industry leader in the ...
... March 7 Novavax, Inc.,(Nasdaq: NVAX ) a ... and Chief Executive Officer, will be presenting at,the Partnering ... on March 11,2008 in Washington D.C. Dr. Singhvi will ... the area of vaccine development to,protect against H5N1 pandemic ...
... Calif., March 7 Genoptix, Inc.,(Nasdaq: GXDX ), ... in the 11th Annual Lehman Brothers Global,Health Care Conference ... Fla.,March 18 - 20, 2008., Dr. Tina Nova ... will present at the conference on Tuesday, March 18, ...
... to protect its Intellectual Property that, has been employed in Minimally Invasive ... ... decade, MARIETTA, Ga., March 7 In a much anticipated decision,Judge ... personally liable for expenses and attorneys,fees incurred by ERBE while defending against ...
... Liverpool School of Tropical Medicine has received a $30 million ... the control and treatment of malaria in pregnancy in Africa, ... directly benefit the 50 million women who face exposure to ... research at Liverpool and at 38 partner institutions in 27 ...
Cached Medicine News:Health News:Vion Pharmaceuticals Regains NASDAQ Listing Compliance 2Health News:MGT Comments on American Cancer Society's Decision to Endorse CT Colonography 2Health News:MGT Comments on American Cancer Society's Decision to Endorse CT Colonography 3Health News:MGT Comments on American Cancer Society's Decision to Endorse CT Colonography 4Health News:Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference 2Health News:ERBE Perseveres Yet Again in Opposition to Dr. Jerome Canady, and is Awarded More Than One Million Dollars 2Health News:LSTM to lead $30 million research program into malaria in pregnancy 2
... a Q-switched ruby laser system ... nm. High Performance Combined with ... combination of high performance and ... mode effectively destroys the (natural ...
... The NMP22 BladderChek Test is the only ... diagnosis of bladder cancer. The NMP22 BladderChek Test ... a single urine sample, that detects elevated levels ... small amounts of NMP22 protein in the urine. ...
... The NMP22® Test Kit is a quantitative ... NMP22 protein. Healthy individuals generally have very small ... the level of NMP22 protein is often elevated ... even at early stages of the disease. The ...
... cystometry and urethral pressure profilometry. The ... bladder to be filled while cystometry ... the catheter in the bladder for ... is standing or sitting. Supplied sterile ...
Medicine Products: